OpenArc Corporate Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2M Buy
103,310
+10,692
+12% +$2.49M 0.31% 59
2026
Q1
$22.6M Buy
92,618
+19,812
+27% +$4.61M 0.32% 54
2025
Q4
$15.1M Buy
+72,806
New +$14.4M 0.25% 59

Other funds holding JNJ

OpenArc Corporate Advisory's JNJ Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, buying an estimated $2.49M and bringing the position to 103,310 shares worth $26.2M. The position accounts for 0.31% of the portfolio, ranked #59.

OpenArc Corporate Advisory first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • OpenArc Corporate Advisory held 103,310 shares of Johnson & Johnson worth $26.2M as of Q2 2026.
  • OpenArc Corporate Advisory bought 10,692 Johnson & Johnson shares in Q2 2026, an estimated $2.49M.
  • Johnson & Johnson made up 0.31% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #59 holding.
  • OpenArc Corporate Advisory first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.